19 Pharmaceutical Companies |Accused Of Medicaid Fraud

BOSTON (CN) - Nineteen drug companies, including Mylan Pharmaceuticals and Sandoz, cheated Medicaid of millions of dollars by inflating their drug prices as much as twentyfold, then using these "fraudulently inflated prices" in sales pitches to customers, who received kickbacks, a Florida company claims on behalf of the federal government.

"To get fraudulent claims paid by the Medicaid Program, the Defendants also routinely made false statements by reporting these same fraudulently inflated prices directly to the states," plaintiff Ven-A-Care says in a False Claims Act complaint.

Here are the defendants: Actavis Mid Atlantic, Alpharma, Alpharma USPD, Barr Pharmaceuticals, Barr Laboratories, Barre Parent Corp., Goldline Laboratories, Ivax Pharmaceuticals, Ivax Corp., Mylan Pharmaceuticals, Mylan Inc., Par Pharmaceutical, Par Pharmaceutical Cos., Sandoz, Schein Pharmaceutical, Teva Pharmaceuticals USA, UDL Laboratories, Watson Pharmaceuticals, and Zenith Goldline Pharmaceuticals.

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Email *

Submit